Apellis Pharmaceuticals Inc
F:1JK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
F:1JK
|
US |
|
Japan Aviation Electronics Industry Ltd
F:8N9
|
JP |
|
F
|
Frey SA
F:943
|
FR |
|
T
|
Trevena Inc
F:6T4
|
US |
|
Dai-ichi Life Holdings Inc
OTC:DCNSF
|
JP |
|
S
|
Star Diamond Corp
F:GOC
|
CA |
|
Odyssey Gold Ltd
F:ODQ
|
AU |
|
L
|
L'Oreal SA
XMUN:LOR
|
FR |
|
H
|
Heineken Holding NV
XMUN:4H5
|
NL |
|
C
|
Comcast Corp
BMV:CMCSA
|
US |
|
A
|
Air China Ltd
F:AD2
|
CN |
|
A
|
Ackermans & Van Haaren NV
F:B3K
|
BE |
|
M
|
Markel Corp
F:MKV
|
US |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
XBER:BKE1
|
ID |
|
C
|
Centrotec SE
XHAM:CEV
|
DE |
|
M
|
Muehl Product & Service AG
F:MPSC
|
DE |
|
S
|
SNP Schneider Neureither & Partner SE
SWB:SHF
|
DE |
|
C
|
Comtech Telecommunications Corp
XMUN:CC6
|
US |
|
Amadeus IT Group SA
F:AI3B
|
ES |
|
B
|
Bayerische Motoren Werke AG
XMUN:BMW
|
DE |
|
W
|
Whirlpool Corp
XMUN:WHR
|
US |
|
P
|
Publicis Groupe SA
XMUN:PU4
|
FR |
|
M
|
Metacon AB (publ)
F:M16
|
SE |
|
B
|
Bushveld Minerals Ltd
OTC:BSHVF
|
ZA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1JK's stock price target?
Not Available
1JK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
6%
The compound annual growth rate for Revenue over the next 3 years is 6%.
What is the Gross Profit forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
5%
The compound annual growth rate for Gross Profit over the next 3 years is 5%.
What is the Operating Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
38%
The compound annual growth rate for Operating Income over the next 3 years is 38%.
What is the Pre-Tax Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
75%
The compound annual growth rate for Net Income over the next 3 years is 75%.
